Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Reduces Stock Holdings in Colgate-Palmolive (NYSE:CL)

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group lowered its position in Colgate-Palmolive (NYSE:CLFree Report) by 12.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,959 shares of the company’s stock after selling 1,736 shares during the quarter. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s holdings in Colgate-Palmolive were worth $1,087,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in CL. Chicago Partners Investment Group LLC boosted its stake in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after acquiring an additional 943 shares during the last quarter. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $1,315,000. Fiduciary Alliance LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $4,066,000. Impact Partnership Wealth LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $803,000. Finally, Barclays PLC boosted its stake in shares of Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CL. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. UBS Group decreased their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Morgan Stanley decreased their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $101.61.

Get Our Latest Stock Analysis on CL

Colgate-Palmolive Price Performance

Shares of CL opened at $90.71 on Thursday. The firm has a market cap of $73.61 billion, a price-to-earnings ratio of 25.77, a PEG ratio of 4.20 and a beta of 0.40. The stock has a 50 day moving average of $89.03 and a 200-day moving average of $94.96. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business posted $0.87 earnings per share. As a group, analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.